Abstract
Background: Obesity has implications for the pharmacodynamics and pharmacokinetics of many commonly administered anaesthetic drugs. The Association of Anaesthetists of Great Britain and Ireland (AAGBI) and Society of Obesity and Bariatric Anaesthesia (SOBA) have issued a joint guideline on the care of obese patients which includes a recommendation that the dosing of a variety of drugs be based on body-weight scalars (such as lean body weight and adjusted body weight) rather than total body weight.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
